$RLAY
Relay Therapeutics (RLAY) Insider Trading
Relay Therapeutics, Inc.Mid Cap$4.0B
Relay Therapeutics insiders sold $129.2M in the last 12 months, led by SVF Pauling (Cayman), with no insider purchases.
View trades →
Insiders (12-Month)
5 Insiders
View trades →
Insider Buys (12-Month)
No insider buys
Latest Buy
No open-market buys on record
Politicians (12-Month)
No politician trades
Recent Insider Trades in RLAY
| Type | Insider | Role | Price | Shares | ΔOwn | Value | Filed |
|---|---|---|---|---|---|---|---|
SELL | Rahmer Peter | Officer | $18.62 | 753 | −0.3% | -$14,021 | Oct 30, '26 |
SELL | Bergstrom Donald A | President, R&D | $18.62 | 2,252 | −0.6% | -$41,932 | Oct 30, '26 |
SELL | Catinazzo Thomas | CFO | $18.62 | 1,469 | −1.4% | -$27,353 | Oct 30, '26 |
SELL10b5-1 | Patel Sanjiv | President & CEO | $18.10 | 48,199 | −3.4% | -$872,402 | Oct 8, '26 |
SELL10b5-1 | Catinazzo Thomas | CFO | $18.59 | 17,717 | −14.4% | -$329,322 | Oct 8, '26 |
SELL10b5-1 | Bergstrom Donald A | President, R&D | $18.97 | 8,530 | −2.1% | -$161,814 | Sep 9, '26 |
SELL10b5-1 | Catinazzo Thomas | CFO | $18.94 | 17,717 | −12.6% | -$335,560 | Sep 9, '26 |
SELL10b5-1 | Patel Sanjiv | President & CEO | $18.94 | 48,199 | −3.3% | -$912,889 | Sep 9, '26 |
SELL10b5-1 | Rahmer Peter | Chief Corporate Development Officer | $20.03 | 4,508 | −2.0% | -$90,295 | Aug 28, '26 |
SELL | SVF Pauling (Cayman) Ltd | 10% Owner | $19.40 | 6,000,000 | −21.5% | -$116,400,000 | Aug 28, '26 |
SELL10b5-1 | Patel Sanjiv | President & CEO | $20.33 | 48,199 | −3.2% | -$979,886 | Aug 18, '26 |
SELL10b5-1 | Catinazzo Thomas | CFO | $19.74 | 17,717 | −11.2% | -$349,734 | Aug 18, '26 |
SELL | Catinazzo Thomas | CFO | $18.61 | 1,459 | −0.9% | -$27,152 | Jul 30, '26 |
SELL | Rahmer Peter | Cheif Corporate Development Officer | $18.61 | 748 | −0.3% | -$13,920 | Jul 30, '26 |
SELL | Bergstrom Donald A | President, R&D | $18.61 | 2,237 | −0.5% | -$41,631 | Jul 30, '26 |
SELL10b5-1 | Bergstrom Donald A | President, R&D | $18.71 | 8,660 | −2.1% | -$162,029 | Jul 8, '26 |
SELL10b5-1 | Patel Sanjiv | President & CEO | $19.58 | 48,199 | −3.1% | -$943,736 | Jul 8, '26 |
SELL10b5-1 | Catinazzo Thomas | CFO | $18.69 | 17,717 | −10.0% | -$331,131 | Jul 8, '26 |
SELL10b5-1 | Rahmer Peter | Chief Corporate Development Officer | $19.09 | 50,000 | −17.9% | -$954,500 | Jul 2, '26 |
SELLOE+Sale10b5-1 | Catinazzo Thomas | CFO | $16.97 | 187,163 | −51.3% | -$3,176,865 | Jun 24, '26 |
SELLOE+Sale10b5-1 | Bergstrom Donald A | President, R&D | $16.94 | 93,456 | −18.3% | -$1,583,145 | Jun 24, '26 |
SELL10b5-1 | Catinazzo Thomas | CFO | $12.86 | 17,717 | −8.3% | -$227,841 | May 14, '26 |
SELL | Catinazzo Thomas | CFO | $14.79 | 972 | −0.5% | -$14,376 | Apr 30, '26 |
SELL | Rahmer Peter | Chief Corporate Development Officer | $14.79 | 753 | −0.3% | -$11,137 | Apr 30, '26 |
SELL | Bergstrom Donald A | President, R&D | $14.79 | 1,490 | −0.4% | -$22,037 | Apr 30, '26 |
SELLOE+Sale10b5-1 | Catinazzo Thomas | CFO | $13.19 | 19,517 | −8.4% | -$257,498 | Apr 10, '26 |
SELL10b5-1 | Catinazzo Thomas | CFO | $10.06 | 17,717 | −7.1% | -$178,233 | Mar 11, '26 |
SELL | Bergstrom Donald A | President, R&D | $7.72 | 21,581 | −4.9% | -$166,677 | Jan 29, '26 |
SELL | Rahmer Peter | Chief Corporate Development Officer | $7.71 | 13,038 | — | -$100,473 | Jan 29, '26 |
SELL | Catinazzo Thomas | CFO | $7.71 | 15,515 | −5.9% | -$119,631 | Jan 29, '26 |
SELL | Patel Sanjiv | President & CEO | $7.82 | 43,168 | −2.7% | -$337,574 | Jan 7, '26 |
Older than 12 months | |||||||
SELL | Patel Sanjiv | President & CEO | $7.00 | 62,073 | −3.8% | -$434,511 | Nov 4, '25 |
SELL | Rahmer Peter | Chief Corporate Development Officer | $7.40 | 40,529 | −10.7% | -$299,949 | Oct 30, '25 |
SELL | Catinazzo Thomas | CFO | $7.29 | 21,664 | −6.5% | -$157,931 | Oct 30, '25 |
SELL | Bergstrom Donald A | President, R&D | $7.29 | 30,897 | −5.6% | -$225,239 | Oct 30, '25 |